Efficacy, Safety and Pharmacokinetics of QAV680 Versus Placebo in Patients With Asthma
Clinical trial NCT01103037 · TERMINATED
Trial details
- NCT number
- NCT01103037
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2010-09-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.